Freezing therapy for small, early-stage breast cancer
Part of Cancer, Skin clinical trials.
This study tests whether freezing a small breast tumor (cryoablation) is a safe and effective treatment option for older adults with early-stage, hormone-receptor-positive breast cancer. Instead of surgery, the goal is to destroy the tumor by freezing it in place.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 70 or older
- You have invasive ductal carcinoma (a common type of breast cancer) confirmed by biopsy
- Your tumor is 1.5 cm or smaller and is in one location only
- Your cancer is hormone-receptor-positive (ER+/PR+) and HER2-negative, with low-risk features
- Your lymph nodes show no signs of cancer (clinically N0)
- You have not had prior radiation or surgery (beyond the biopsy) on this breast
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether cryoablation (freezing abnormal breast tissue) can treat DCIS, a non-invasive early breast cancer, without surgical lumpectomy. It aims to see if a less invasive approach could help people with small, limited-area DCIS while avoiding some effects of surgery.
This study tests a freezing treatment called cryoablation for early-stage breast cancer in people aged 70 and older. It aims to see if freezing the tumor can be a safe and effective alternative to surgery for those who may be older or frail.
This trial tests cryoablation (freezing the tumor with a needle) as a way to treat small, low-risk breast cancers without surgery. It is for women 50 or older whose cancers are hormone-receptor-positive and haven't spread to lymph nodes.
This study tests if freezing a very small early-stage breast tumor (cryoablation) can be as effective as surgery. It may be an option for people whose tumor is small enough and hasn't spread to lymph nodes or elsewhere.
This study tests cryoablation (freezing) to treat small, early stage breast cancers that are hormone receptor positive and HER2 negative. It may be an option for postmenopausal women who want to avoid surgery.
This trial compares freezing the tumor with surgery to remove it in women over 60 with early-stage, hormone-sensitive breast cancer. The goal is to see if freezing is as effective and less invasive.
Hear when a new Low-Risk, Early Stage Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.